Warning letter
MS Bionic: warning letter of May 3, 2017
FDA warning letter UCM569188 · Los Angeles District Office
Key facts
| Reference number | UCM569188 |
|---|---|
| Company | MS Bionic |
| Subject | Unapproved New Drugs/Misbranded |
| Issue date | May 3, 2017 |
| Posted date | May 3, 2017 |
| Issuing office | Los Angeles District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.75(h)(1), 101, 101.4, 101.36, 111, 111.75, 111.103, 111.153, 111.210, 111.353, 111.355, 111.375 and 21 more |
| Country | 3 |
| Inspection city | Gardena |
| Inspection ZIP | 90248 |
| Inspection start date | Nov 15, 2016 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: